Welcome to Wopular's coverage of Otc Drug, Flaxosmithkline.
Wopular aggregates news headlines from the top newspapers and
news sources. To the right are articles about
Otc Drug, Flaxosmithkline that have been featured on main sections
of the site.
Below are topics about Otc Drug, Flaxosmithkline. (Click on "all"
to view all articles related to the topic, including articles NOT about
Otc Drug, Flaxosmithkline.
U.S. government health regulators will allow GlaxoSmithKline to continue selling a controversial diabetes pill but will restrict access to the once-blockbuster drug because of heart attack risks.